Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Elizabeth Hexner, MD

Elizabeth Hexner, MD Physician

Medical Director, Center for Cellular Immunotherapies Associate Professor of Medicine at the Hospital of the University of Pennsylvania Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Hexner is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Clinical Expertise:

  • Acute Lymphocytic Leukemia
  • Acute Myelogenous Leukemia
  • Acute Promyelocytic Leukemia
  • Adult T-Cell Leukemia
  • Adult T-Cell Lymphoma
  • AIDS Related Malignancies
  • Amyloidosis
  • Anaplastic Large Cell Lymphoma
  • Blood Cancer
  • Bone Marrow Biopsy
  • Bone Marrow Failure Syndromes
  • Burkitt Lymphoma
  • Cancer During Pregnancy
  • Castleman Disease
  • Chronic Lymphocytic Leukemia
  • Chronic Myelocytic Leukemia
  • Chronic Myelomonocytic Leukemia
  • CNS Lymphoma
  • Cutaneous Lymphoma
  • Eosinophilic Granuloma
  • Erdheim-Chester Disease
  • Essential Thrombocytosis
  • Graft Versus Host Disease
  • Hairy Cell Leukemia
  • Histiocytosis
  • HIV Lymphoma
  • HIV Malignancies
  • Hodgkin Lymphoma
  • Intraocular Lymphoma
  • Large Granular Lymphocytic Leukemia
  • Light Chain Disorders
  • Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Lymphoma
  • Monoclonal Gammopathy of Undetermined Significance
  • Mucosa-Associated Lymphoid Tissue Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes (MDS)
  • Non-Hodgkin Lymphoma
  • Pelvic Malignancy During Pregnancy
  • Peripheral T-Cell Lymphoma
  • Plasma Cell Dyscrasia
  • POEMS Syndrome
  • Polycythemia
  • Primary Myelofibrosis
  • Prolymphocytic Leukemia
  • Refractory Anemia With Excess Blasts
  • Sezary Syndrome
  • Transformed Lymphoma
  • Waldenstrom Macroglobulinemia (WM)
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA (DO NOT USE)
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Columbia University
Residency: NewYork-Presbyterian/Columbia University Medical Center
Fellowship: Hospital of the University of Pennsylvania


American Society of Hematology, International NHLBI (NIH), National Racing to Register, National

Hospital Affiliation

Dr. Hexner is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Myeloproliferative Disorders
Umbilical Cord Blood Transplantation

Selected Publications:

Yacoub Abdulraheem, Mascarenhas John, Kosiorek Heidi, Prchal Josef T, Berenzon Dmitriy, Baer Maria R, Ritchie Ellen, Silver Richard T, Kessler Craig, Winton Elliott, Finazzi Maria Chiara, Rambaldi Alessandro, Vannucchi Alessandro M, Leibowitz David, Rondelli Damiano, Arcasoy Murat O, Catchatourian Rosalind, Vadakara Joseph, Rosti Vittorio, Hexner Elizabeth, Kremyanskaya Marina, Sandy Lonette, Tripodi Joseph, Najfeld Vesna, Farnoud Noushin, Papaemmanuil Elli, Salama Mohamed, Singer-Weinberg Rona, Mesa Ruben: Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea Blood : 2019.

Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer M R, Ritchie E, Silver R T, Kessler C, Winton E, Finazzi M C, Rambaldi A, Vannucchi A M, Leibowitz D, Rondelli D, Arcasoy M O, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama M E, Weinberg R S, Rampal R, Goldberg J D, Mesa R, Dueck A C, Hoffman R: A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis. Leukemia : 2019.

Linaburg Taylor, Davis Adam R, Frey Noelle V, Khawaja Muhammad R, Landsburg Daniel J, Schuster Stephen J, Svoboda Jakub, Li Yimei, Borovskiy Yuliya, Olson Timothy S, Bagg Adam, Hexner Elizabeth O, Babushok Daria V: Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia. PloS one 14 (4): e0215021,2019.

Soderquist, Craig R, Ewalt, Mark D, Czuchlewski, David R, Geyer, Julia T, Rogers, Heesun J, Hsi, Eric D, Wang, Sa A, Bueso-Ramos, Carlos E, Orazi, Attilio, Arber, Daniel A, Hexner, Elizabeth O, Babushok, Daria V, Bagg, Adam: Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 31 (5): 690-704,2018.

Hartwell, Matthew J, Özbek, Umut, Holler, Ernst, Renteria, Anne S, Major-Monfried, Hannah, Reddy, Pavan, Aziz, Mina, Hogan, William J, Ayuk, Francis, Efebera, Yvonne A, Hexner, Elizabeth O, Bunworasate, Udomsak, Qayed, Muna, Ordemann, Rainer, Wölfl, Matthias, Mielke, Stephan, Pawarode, Attaphol, Chen, Yi-Bin, Devine, Steven, Harris, Andrew C, Jagasia, Madan, Kitko, Carrie L, Litzow, Mark R, Kröger, Nicolaus, Locatelli, Franco, Morales, George, Nakamura, Ryotaro, Reshef, Ran, Rösler, Wolf, Weber, Daniela: An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI insight 3 (16): 2018.

Hexner, Elizabeth: CD44: expanding the toolKIT. Blood 132 (18): 1863-1863,2018.

Crisalli, Lisa M, Hinkle, Joanne T, Walling, Christopher C, Sell, Mary, Frey, Noelle V, Hexner, Elizabeth O, Loren, Alison W, Luger, Selina M, Stadtmauer, Edward A, Porter, David L, Reshef, Ran: Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24 (6): 1203-1208,2018.

Reshef, Ran, Ganetsky, Alex, Acosta, Edward P, Blauser, Robin, Crisalli, Lisa, McGraw, Jessica, Frey, Noelle V, Hexner, Elizabeth O, Hoxie, James A, Loren, Alison W, Luger, Selina M, Mangan, James, Stadtmauer, Edward A, Mick, Rosemarie, Vonderheide, Robert H, Porter, David L: Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation : 2018.

Aynardi, Jason, Manur, Rashmi, Hess, Paul R, Chekol, Seble, Morrissette, Jennifer J D, Babushok, Daria, Hexner, Elizabeth, Rogers, Heesun J, Hsi, Eric D, Margolskee, Elizabeth, Orazi, Attilio, Hasserjian, Robert, Bagg, Adam: JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group. British journal of haematology 182 (1): 78-85,2018.

Ganetsky, Alex, Han, Jennifer H, Hughes, Mitchell E, Babushok, Daria V, Frey, Noelle V, Gill, Saar I, Hexner, Elizabeth O, Loren, Alison W, Luger, Selina M, Mangan, James K, Martin, Mary Ellen, Smith, Jacqueline, Freyer, Craig W, Gilmar, Cheryl, Schuster, Mindy, Stadtmauer, Edward A, Porter, David L: Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America : 2018.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-151
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 662-6348
Patient appointments: 800-789-7366 (PENN)

Related Links